417 related articles for article (PubMed ID: 14597516)
1. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
[TBL] [Abstract][Full Text] [Related]
2. An analysis of risk for secondary hemorrhage in traumatic hyphema.
Rahmani B; Jahadi HR; Rajaeefard A
Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
Rahmani B; Jahadi HR
Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
[TBL] [Abstract][Full Text] [Related]
4. Traumatic hyphema: outcomes of outpatient management.
Shiuey Y; Lucarelli MJ
Ophthalmology; 1998 May; 105(5):851-5. PubMed ID: 9593386
[TBL] [Abstract][Full Text] [Related]
5. Medical interventions for traumatic hyphema.
Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD005431. PubMed ID: 30640411
[TBL] [Abstract][Full Text] [Related]
6. Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema.
Karkhaneh R; Naeeni M; Chams H; Abdollahi M; Mansouri MR
Eur J Ophthalmol; 2003; 13(1):57-61. PubMed ID: 12635675
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid.
Beiran I; Talmon T; Miller B
Isr Med Assoc J; 2002 Nov; 4(11):1009-10. PubMed ID: 12489492
[TBL] [Abstract][Full Text] [Related]
8. Topical aminocaproic acid in the treatment of traumatic hyphema.
Crouch ER; Williams PB; Gray MK; Crouch ER; Chames M
Arch Ophthalmol; 1997 Sep; 115(9):1106-12. PubMed ID: 9298049
[TBL] [Abstract][Full Text] [Related]
9. Outpatient management of traumatic hyphemas in children.
Coats DK; Viestenz A; Paysse EA; Plager DA
Binocul Vis Strabismus Q; 2000; 15(2):169-74. PubMed ID: 10893460
[TBL] [Abstract][Full Text] [Related]
10. Medical interventions for traumatic hyphema.
Woreta FA; Lindsley KB; Gharaibeh A; Ng SM; Scherer RW; Goldberg MF
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD005431. PubMed ID: 36912744
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children.
Teboul BK; Jacob JL; Barsoum-Homsy M; Brunette I; Chevrette L; Milot J; Orquin J; Polomeno RC; Quigley MG
Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257
[TBL] [Abstract][Full Text] [Related]
12. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
[TBL] [Abstract][Full Text] [Related]
13. Medical interventions for traumatic hyphema.
Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
Cochrane Database Syst Rev; 2011 Jan; (1):CD005431. PubMed ID: 21249670
[TBL] [Abstract][Full Text] [Related]
14. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001).
Romano PE; Robinson JA
Binocul Vis Strabismus Q; 2000; 15(2):175-86. PubMed ID: 10893461
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
Kikura M; Levy JH; Tanaka KA; Ramsay JG
J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
[TBL] [Abstract][Full Text] [Related]
16. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
[TBL] [Abstract][Full Text] [Related]
18. [Traumatic hyphema caused by eye injuries].
Luksza L; Homziuk M; Nowakowska-Klimek M; Glasner L; Iwaszkiewicz-Bilikiewicz B
Klin Oczna; 2005; 107(4-6):250-1. PubMed ID: 16118929
[TBL] [Abstract][Full Text] [Related]
19. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid in the treatment of pediatric traumatic hyphema.
Albiani DA; Hodge WG; Pan YI; Urton TE; Clarke WN
Can J Ophthalmol; 2008 Aug; 43(4):428-31. PubMed ID: 18711456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
